Antibody-Capture Elisa

Lab Reagents

Antibody Elisa Laboratories manufactures the antibody-capture elisa reagents distributed by Genprice. The Antibody-Capture Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact antibody elisa. Other Antibody-Capture products are available in stock. Specificity: Antibody-Capture Category: Elisa

Human Samples information

NT-proBNP (Capture Ab)

abx019243-1mg 1 mg
EUR 828

VAHTS mRNA Capture Beads

N401-01 24 rxn
EUR 171.6

VAHTS mRNA Capture Beads

N401-02 96 rxn
EUR 306

Anti-Troponin I (185-195) Capture Antibody

A2104-100 100 µg
EUR 381.6

Anti-Troponin I (85-92) Capture Antibody

A2107-100 100 µg
EUR 381.6

Anti-NT-proBNP (13-27) Capture Antibody

A2112-100 100 µg
EUR 381.6

Anti-NT-proBNP (64-67) Capture Antibody

A2114-100 100 µg
EUR 454.8

ExoMS Total Protein Capture Kit

EXOMS120A-8 8 reactions
EUR 572.4

Avian Influenza A Nucleoprotein Antigen Capture ELISA Kit

DEIA2026 2 x 96T
EUR 1554
Description: This kit is a highly sensitive and specific enzyme immunoassay for the detection of Influenza A nucleoprotein antigen in complex sample matrices derived from both human and veterinary sources.

Mouse antibody for Hepatitis B virus sAg. capture

1834 100 ug
EUR 386.26
Description: This is purified Mouse monoclonal antibody against Hepatitis B virus sAg capture for WB, ELISA.

Anti-Influenza A Virus Mouse IgG2b Capture Antibody

A2083-100 100 µg
EUR 381.6

Cannabinoid (THC)-HRP Antigen (AG310 (capture))

VAng-Cr3668-1mg 1 mg
EUR 967.2
Description: Cannabinoid (THC)-HRP Antigen, matched pairs: AG310 (capture); Used for ELISA.

Cannabinoid (THC)-HRP Antigen (AG309 (capture))

VAng-Cr3669-1mg 1 mg
EUR 885.6
Description: Cannabinoid (THC)-HRP Antigen, matched pairs: AG309 (capture); Linking Position: Position 8; Used for ELISA.

Methylamp Methylated DNA Capture (MeDIP) Kit 

P-1015-24 24 Reactions
EUR 424.6

Methylamp Methylated DNA Capture (MeDIP) Kit 

P-1015-48 48 Reactions
EUR 712.8

Methylamp Methylated DNA Capture (MeDIP) Kit 

P-1015
  • EUR 1050.06
  • EUR 424.60
  • EUR 712.80
  • 48 Reactions
  • 24 Reactions
  • 48 Reactions

Dengue Virus IgM µ-capture ELISA Kit (Human) (OKNA00132)

OKNA00132 96 Wells
EUR 505.2
Description: Description of target: Dengue fever, also known as breakbone fever, is an infectious tropical disease caused by the dengue virus andtransmitted by mosquitoes. Dengue fever virus (DENV) is a virus of the family Flaviviridae, genus Flavivirus and contains a single-stranded RNA genome with positive polarity. There are four serotypes of the virus, which are referred to as DENV-1, DENV-2, DENV-3 and DENV-4.The geographical distribution is around the equator, particularly Latin America, Central Africa, India, Southeast Asia, Western Pacific and South of the USA.Dengue viruses are transmitted to humans through the bites of infective female yellow fever mosquitoes (Stegomyia aegypti, formerly Aedes aegypti). The mosquitoes generally acquire the virus while feeding on the blood of an infected person. After virus incubation for eight to ten days, an infected mosquito is capable, during probing and blood feeding, of transmitting the virus for the rest of its life.Yellow fever mosquitoes are well adapted to living in close proximity to humans, and to feeding off people rather than other vertebrates. They prefer to lay their eggs in artificial water containers, such as flower vases, uncovered barrels, buckets and discarded tires.The incubation period ranges from 3-14 days, but most often it is 4-7 days. Typically, people infected with dengue virus are asymptomatic or only have symptoms of a common cold. The characteristic symptoms of dengue are sudden-onset fever (up to 40 C) with intense headache (especially behind the eyes), and muscle and joint pain. In combination with a skin rash this symptoms are known as the „dengue triad“. This usually lasts 3-7 days. In some patients the disease proceeds to a critical phase. Dengue Hemorrhagic Fever (DHF) or Dengue Shock Syndrome (DSS) occur in less than 5 % of all cases of dengue. About 1-5 % of severe cases are fatal. In individual epidemics the case-fatality rate may reach up to 15 %.Infection with one serotype is believed to produce lifelong immunity to that serotype but only short term protection against the others. Secondary infection with a different serotype may result in severe clinical manifestations. There is no vaccination available.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Reverse Capture Sandwich ELISA ;Sensitivity: Sensitivity is determined as the probability of the assay indicating a positive score in samples with the specific analyte present: > 98%